Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,973 | 15,225 | 23,385 | 27,884 | 36,958 |
| Marketable Securities | 92,755 | 111,337 | 114,885 | 126,598 | 116,874 |
| Receivables | 8,306 | 5,753 | 5,525 | 4,682 | 4,560 |
| Inventories | 7,611 | 7,933 | 8,274 | 8,914 | 10,393 |
| TOTAL | $124,645 | $143,219 | $155,748 | $171,684 | $172,909 |
| Non-Current Assets | |||||
| PPE Net | 18,620 | 19,404 | 19,921 | 19,707 | 20,967 |
| Investments And Advances | 52,274 | 38,600 | 36,423 | 35,781 | 42,797 |
| Intangibles | 4,221 | 4,386 | 4,417 | 0 | 0 |
| Other Non-Current Assets | 13,716 | 14,141 | 13,452 | 12,298 | 11,939 |
| TOTAL | $88,831 | $76,531 | $74,213 | $67,786 | $75,703 |
| Total Assets | $213,476 | $219,750 | $229,961 | $239,470 | $248,612 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,286 | 1,210 | 2,279 | 1,358 | 1,865 |
| Accrued Expenses | 8,306 | 6,397 | 5,033 | 8,302 | 8,196 |
| TOTAL | $16,102 | $11,555 | $12,733 | $15,775 | $17,621 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 5,196 | 2,640 | 4,145 | 5,251 | 6,653 |
| Other Non-Current Liabilities | 17,099 | 17,472 | 17,816 | 17,444 | 17,689 |
| TOTAL | $17,099 | $17,472 | $17,816 | $17,444 | $17,689 |
| Total Liabilities | $33,201 | $29,027 | $30,549 | $33,219 | $35,310 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 106,674 | 106,607 | 106,319 | 106,028 | 105,483 |
| Common Shares | 1,066 | 1,066 | 1,063 | 1,057 | 1,053 |
| Retained earnings | -251,887 | -239,471 | -227,114 | -216,853 | -206,256 |
| TOTAL | $180,275 | $190,723 | $199,412 | $206,251 | $213,302 |
| Total Liabilities And Equity | $213,476 | $219,750 | $229,961 | $239,470 | $248,612 |